MAPT and amyotrophic lateral sclerosis: Although 21.7% of c9orf72 pathogenic variant carriers with a predominant mixed/ALS-MP had confirmed motor neuron disease, in none of the patients with a GRN or MAPT pathogenic variant, motor neuron disease was diagnosed.